Helen Dakin

Has grant

University Research Lecturer

University of Oxford

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Helen Dakin is a University Research Lecturer at the University of Oxford, UK. Her research focuses on health economics, particularly in the assessment of cost-effectiveness and outcomes in medical treatments and interventions. Recent articles authored by Dr. Dakin include studies on diabetes simulation models, nail bed repair in children, and treatment strategies for Dupuytren's disease.

Recent Grants

Grant: Close

Senior Research Fellowship

Open Date: 2020-03-01

Close Date: 2021-03-01

Grant: Close

Using big data to improve population health and resource allocation for people with diabetes in Malaysia

Open Date: 2019-12-01

Close Date: 2022-03-01

Grant: Close

The clinical effectiveness and cost effectiveness of surgery for early osteoarthritis of the hip and knee joint (SCORE)

Open Date: 2019-06-01

Close Date: 2021-01-01

Grant: Close

DRAFFT 2: Distal Radius Acute Fracture Fixation Trial 2

Open Date: 2016-01-01

Close Date: 2020-01-01

Grant: Close

Clinical and cost effectiveness of progressive exercise compared to best practice advice, with or without corticosteroid injection, for the treatment of rotator cuff disorders: a 2x2 factorial randomised controlled trial (The GRASP trial)

Open Date: 2016-01-01

Close Date: 2020-01-01

Articles (13)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (17)

Chris Peach

Professor

Manchester University NHS Foundation Trust

UNITED KINGDOM

Helen Dakin

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (13)

Using QALYs as an Outcome for Assessing Global Prediction Accuracy in Diabetes Simulation Models

Estimating Risk Factor Time Paths Among People with Type 2 Diabetes and QALY Gains from Risk Factor Management

Rationing in an Era of Multiple Tight Constraints: Is Cost-Utility Analysis Still Fit for Purpose?

Effectiveness of nail bed repair in children with or without replacing the fingernail: NINJA multicentre randomized clinical trial.

Cost-effectiveness of Replacing Versus Discarding the Nail in Children with Nail Bed Injury

Cost-effectiveness of adalimumab for early-stage Dupuytren’s disease

Corrigendum: Progressive exercise compared with best-practice advice, with or without corticosteroid injection, for rotator cuff disorders: the GRASP factorial RCT

Anti-tumour necrosis factor therapy for early-stage Dupuytren's disease (RIDD): a phase 2b, randomised, double-blind, placebo-controlled trial.

Early-stage Dupuytren's disease treatment; a promising next step?

Surgical fixation with K-wires versus casting in adults with fracture of distal radius: DRAFFT2 multicentre randomised clinical trial.

Progressive exercise compared with best-practice advice, with or without corticosteroid injection, for rotator cuff disorders: the GRASP factorial RCT

Lifetime cost-effectiveness simulation of once-weekly exenatide in type 2 diabetes: A cost-utility analysis based on the EXSCEL trial.

Progressive exercise compared with best practice advice, with or without corticosteroid injection, for the treatment of patients with rotator cuff disorders (GRASP): a multicentre, pragmatic, 2 × 2 factorial, randomised controlled trial.

Collaborators (17)

Chris Peach

Jose Leal

Apostolos Tsiachristas

Andrew Carr

Susan Dutton

An Tran-Duy

David J. Beard

Lucy Cureton

Joshua P Totty

Amy Taylor

Ryckie Wade

Alastair Gray

Jamie Stokes

Frauke Becker

Jonathan Cook

Jagdeep Nanchahal

David Keene

Make your next move.